SIGA Technologies Revenue and Competitors
Estimated Revenue & Valuation
- SIGA Technologies's estimated annual revenue is currently $7.5M per year.
- SIGA Technologies's estimated revenue per employee is $86,207
- SIGA Technologies's total funding is $84M.
Employee Data
- SIGA Technologies has 87 Employees.
- SIGA Technologies grew their employee count by 9% last year.
SIGA Technologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is SIGA Technologies?
SIGA Technologies, Inc. is a development stage biotechnology company. Its focus is on the discovery, development and commercialization of vaccines, antibiotics and novel anti-infectives for serious infectious diseases. Its lead vaccine candidate is for the prevention of group A streptococcal pharyngitis or "strep throat." The Company is developing a technology for the mucosal delivery of its vaccines which may allow those vaccines to activate the immune system at the mucus lined surfaces of the body the mouth, the nose, the lungs and the gastrointestinal and urogenital tracts the sites of entry for most infectious agents.
keywords:N/A
$84M
Total Funding
87
Number of Employees
$7.5M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SIGA Technologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | EVP and Chief Financial Officer | Reveal Email/Phone |
2 | Senior Director, Poxvirus Research | Reveal Email/Phone |
3 | Director, Contracts & Project Management | Reveal Email/Phone |
4 | CEO | Reveal Email/Phone |
5 | Director Business Development | Reveal Email/Phone |
6 | Associate Director Animal Studies | Reveal Email/Phone |
7 | Directer Analytical Science | Reveal Email/Phone |
8 | VP Controller | Reveal Email/Phone |
9 | EVP, Chief Medical Officer | Reveal Email/Phone |
10 | Accounting Manager | Reveal Email/Phone |
SIGA Technologies News
Get SIGA Technologies alerts: A number of institutional investors and hedge funds have recently bought and sold shares of the business. Barclays...
SIGA We believe fundamentally sound stocks, SIGA Technologies (SIGA) and Information Services Group (III), which are currently trading...
FMC Corp: I say, buy [agriculture stocks] when the rain is coming down. SIGA Technologies Inc (SIGA). Share price year to date. WATCHLIST+.
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.3M | 87 | -7% | $144M |
#2 | $15M | 87 | 7% | $2.2B |
#3 | $12.6M | 87 | 6% | N/A |
#4 | $25M | 87 | 4% | N/A |
#5 | $12.2M | 87 | -2% | N/A |
SIGA Technologies Executives
| Name | Title |
|---|---|
| Dennis Hruby | Executive Vice President and Chief Scientific Officer |
| Tove Bolken | SVP, Operations & Chief Supply Chain Officer |
| Herb Vloedman | Senior Vice President and CIO |
| Daniel Luckshire | EVP and Chief Financial Officer |
| Phil Gomez | CEO |
| Kelly Donelan | Senior Vice President, Operations & Chief Supply Chain Officer |
| Dennis Hruby | Executive Vice President and Chief Scientific Officer |
| Tove Bolken | SVP, Operations & Chief Supply Chain Officer |
| Herb Vloedman | Senior Vice President and CIO |
| Marianna Anesti | VP Business Development & Corporate Strategy |
| Daniel Luckshire | EVP and Chief Financial Officer |
| Kevin Buckley | VP Controller |
| Kelly Donelan | Senior Vice President, Operations & Chief Supply Chain Officer |
| Marianna Anesti | Vice President of Corporate Strategy & Business Development |